x
- Industry: Pharma & Lifesciences
- Study Type: Epileptic Case Study
- Client: A leading Research & Consultancy Firm
Background & Key Objectives
- To gain knowledge and in-depth insights from Epilepsy care professionals, like Neurologists, Epileptologists and general physicians on current standards of patient management.
- Deep-dive in understanding Epilepsy universe and understand HCP’s role in this environment.
- Comparison of available pharmacotherapy agents, including client’s own product
- Usage trends between Generics versus Originators
Methodology & Approach
- The study was executed in 2 phases – quantitative followed by qualitative.
- Length of Interview of the quantitative survey: 30 minutes
- Length of Interview of the qualitative survey: 60 minutes
- Target markets: UK and EU4
- The surveys consisted of questions divided into different sections:
- Epilepsy patient management (process of treatment decision, treatment lines and switching process).
- Patient journey and challenges (impact of epilepsy in patient’s life, financial burden and associated care)
- Treatment trend (switch from the 3rd generation to 4th generation drugs, shift from originators to generics and vice versa, challenges faced on treatment shift, patient’s response).
- Overall disease burden and treatment decision drivers.
- We deployed a specialist team of healthcare researchers, comprised of experienced Research analysts with skillsets for healthcare discussion with specialists and project managers with experience in data analysis
Our Solution
- The study results helped the client fill the data gaps on current standards and trends in patient care and patients' response and physician opinion of their product.
- This aided the client's medical affairs and the marketing team in redirecting their efforts to the existing messaging and physician feedback on their product.
- Data was shared in Excel/SPSS and Transcripts (excel spreadsheet) format.